Medtronic affirmed FDA’s approval of Prestige LP to treat cervical disc disease at two adjacent levels. Unlike fusion, Prestige LP is designed to allow motion in the neck at the operated levels.
The approval decision was filed in FDA’s Premarket Approval database on 7/7/16.
Two pivotal clinical trials, single-level and two-level, were conducted to support the safety, effectiveness and FDA approval of the device. The two-level clinical trial included 397 patients (209 investigational and 188 control ) at 30 U.S. sites around the U.S. At 24 months, the Prestige group demonstrated statistical superiority in overall success vs. those treated with a two-level anterior cervical discectomy and fusion (ACDF).
The low-profile Prestige LP Disc features a ball-and-trough design with a titanium ceramic composite disc to offer improved wear resistance. It is implanted using an anterior approach.
Medtronic’s entry into the 2-level market is expected to put competitive pressure on Zimmer Biomet and Mobi-C. To date, Prestige LP and LDR’s Mobi-C are the only two cervical discs approved for 2-level cervical disc replacement in the U.S. (Zimmer Biomet just recently completed its acquisition of LDR.)
Sources: Medtronic plc, ORTHOWORLD Inc.
Medtronic affirmed FDA's approval of Prestige LP to treat cervical disc disease at two adjacent levels. Unlike fusion, Prestige LP is designed to allow motion in the neck at the operated levels.
The approval decision was filed in FDA's Premarket Approval database on 7/7/16.
Two pivotal clinical trials, single-level and two-level, were...
Medtronic affirmed FDA’s approval of Prestige LP to treat cervical disc disease at two adjacent levels. Unlike fusion, Prestige LP is designed to allow motion in the neck at the operated levels.
The approval decision was filed in FDA’s Premarket Approval database on 7/7/16.
Two pivotal clinical trials, single-level and two-level, were conducted to support the safety, effectiveness and FDA approval of the device. The two-level clinical trial included 397 patients (209 investigational and 188 control ) at 30 U.S. sites around the U.S. At 24 months, the Prestige group demonstrated statistical superiority in overall success vs. those treated with a two-level anterior cervical discectomy and fusion (ACDF).
The low-profile Prestige LP Disc features a ball-and-trough design with a titanium ceramic composite disc to offer improved wear resistance. It is implanted using an anterior approach.
Medtronic’s entry into the 2-level market is expected to put competitive pressure on Zimmer Biomet and Mobi-C. To date, Prestige LP and LDR’s Mobi-C are the only two cervical discs approved for 2-level cervical disc replacement in the U.S. (Zimmer Biomet just recently completed its acquisition of LDR.)
Sources: Medtronic plc, ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
